Where Global Innovation
and Capital Meet
Sectors Consumer University Energy Financial Healthcare Industrial IT Media Services Telecoms Transport The Art of CVC Startups

Page 127

Delivery Hero swoops for InstaShop in $360m deal

On-demand grocery delivery service InstaShop had reportedly raised just $7m prior to the acquisition, with Souq and Jabbar Internet exiting.

Aug 28, 2020

BMS to fork over cash for Forbius

Cancer and fibrosis therapy developer Forbius has agreed to be acquired by Bristol Myers Squibb nine years after it was spun off by YM BioSciences.

Aug 27, 2020

Xpeng extracts $1.5bn from initial public offering

The Alibaba, Xiaomi, Foxconn, UCar and Duowan-backed smart electric carmaker has floated in the US through an offering valuing it in excess of $21bn.

Aug 27, 2020

Desktop Metal irons out $2.5bn reverse merger

Desktop Metal, backed by a large consortium of corporates, will merge with special purpose acquisition company Trine to list on the NYSE at a $2.5bn valuation.

Aug 27, 2020

Google to add $100m to Amwell IPO

The Teva, Allianz and Takeda-backed telehealth technology producer has filed to raise up to $100m in an offering that will be boosted by another $100m from Google.

Aug 27, 2020

Cisco signs up for BabbleLabs acquisition

Dell Technologies Capital and Intel Capital are set to exit the audio enhancement technology provider, which has agreed to be bought by Cisco.

Aug 26, 2020

Govertis makes its way to ElevenPaths

The Telefónica subsidiary has bought cyber risk consultancy and software producer Govertis having previously invested through subsidiary ElevenPaths.

Aug 26, 2020

Ant Group advances to IPO filings

Alibaba's financial services spinoff has officially filed for a dual listing in Shanghai and Hong Kong that could potentially raise $30bn.

Aug 26, 2020

Palantir reveals filing for direct listing

The Sompo, Fujitsu and Relx-backed data miner, which has raised some $2.7bn in venture funding, has chosen the New York Stock Exchange to list its shares.

Aug 26, 2020

Yumanity and Proteostasis pursue reverse merger

Yumanity Therapeutics will take over Nasdaq-listed Proteostasis in a reverse merger after raising more than $100m from investors including Biogen, Merck & Co, Pfizer and Sanofi.

Aug 26, 2020

© 2024 Mawsonia Ltd. All rights reserved.
test reg

Login

Not yet subscribed?

See your subscription offers here